dihexa clinical trials human studies status 2026 dihexa clinical trials 2026 20 May 2026 – Celebrating Clinical Trials Day: Clinical Research Through the Ages DIHEXA | Peptide Synthetic |
Description
Treatment with FOXO4-DRI at 25 M in serum-limited senescent fibroblast and keloid organ culture models promoted apoptosis, decreased G0/G1 phase cells, and induced p53-pS15 nuclear exclusion confirmed by Annexin V-FITC/PI apoptosis assays and TUNEL staining of keloid organ cultures at days 3, 7, and 10
Which I am still doing now
Majerova, P
doi:10.1042/bj1990649
